Janice represents clients in the healthcare industry, focusing her practice on the strategic, regulatory and operational needs of health systems, hospitals, academic medical centers, Federally Qualified Health Centers (FQHCs), telehealth providers, and digital start-ups. Her experience as in-house counsel for a large health center provides clients a unique perspective to navigate complex healthcare matters.
Janice provides...
Janice represents clients in the healthcare industry, focusing her practice on the strategic, regulatory and operational needs of health systems, hospitals, academic medical centers, Federally Qualified Health Centers (FQHCs), telehealth providers, and digital start-ups. Her experience as in-house counsel for a large health center provides clients a unique perspective to navigate complex healthcare matters.
Janice provides strategic and regulatory guidance on the 340B Drug Discount Program, including contract pharmacy arrangements, as well as limited distribution network and other specialty pharmacy models. She has represented specialty pharmacies, health care systems, disproportionate share hospitals, federal grantees, and other 340B-covered entities.
She routinely represents FQHCs on various matters related to the Health Center Program. She advises health centers regarding HRSA Operational Site Visits and other government agency audits, billing and contracting advice, guidance on Federal Tort Claims Act coverage and the 340B Drug Discount Program, as well as other regulatory requirements impacting health center compliance.
Additionally, Janice also advises digital and medical technology companies and providers on privacy and security matters. The increased use of Software as a Medical Device (MaSD) and artificial intelligence in medical technology presents unique cybersecurity issues as the FDA and FTC continue to implement regulatory requirements. She provides strategic advice to her medical technology clients on cybersecurity, privacy, and data protection issues.
Throughout her career, she has represented numerous providers with cybersecurity and cyber-liability issues, telehealth, data strategy, security and privacy, licensure and accreditation of health care facilities, Medicare and Medicaid reimbursement, and billing and coding matters. She has also assisted clients in the development and implementation of collaborative care models, clinically integrated networks, clinical trials contracting and reimbursement, patient safety organizations and employer sponsored on-site health clinics.
Janice routinely represents telehealth providers on licensure, credentialing, privileging, online prescribing and corporate practice of medicine matters. She also drafts and reviews contracts for digital health products and services and assists health care clients with security and risk analysis obligations under federal and state laws.
strategic and regulatory guidance on the 340B Drug Discount Program, including contract pharmacy arrangements, as well as limited distribution network and other specialty pharmacy models. She has represented specialty pharmacies, health care systems, disproportionate share hospitals, federal grantees, and other 340B-covered entities.
She routinely represents FQHCs on various matters related to the Health Center Program. She advises health centers regarding HRSA Operational Site Visits and other government agency audits, billing and contracting advice, guidance on Federal Tort Claims Act coverage and the 340B Drug Discount Program, as well as other regulatory requirements impacting health center compliance.
Additionally, Janice also advises digital and medical technology companies and providers on privacy and security matters. The increased use of Software as a Medical Device (MaSD) and artificial intelligence in medical technology presents unique cybersecurity issues as the FDA and FTC continue to implement regulatory requirements. She provides strategic advice to her medical technology clients on cybersecurity, privacy, and data protection issues.
Throughout her career, she has represented numerous providers with cybersecurity and cyber-liability issues, telehealth, data strategy, security and privacy, licensure and accreditation of health care facilities, Medicare and Medicaid reimbursement, and billing and coding matters. She has also assisted clients in the development and implementation of collaborative care models, clinically integrated networks, clinical trials contracting and reimbursement, patient safety organizations and employer sponsored on-site health clinics.
Janice routinely represents telehealth providers on licensure, credentialing, privileging, online prescribing and corporate practice of medicine matters. She also drafts and reviews contracts for digital health products and services and assists health care clients with security and risk analysis obligations under federal and state laws.
Janice represents clients in the healthcare industry, focusing her practice on the strategic, regulatory and operational needs of health systems, hospitals, academic medical centers, Federally Qualified Health Centers (FQHCs), telehealth providers, and digital start-ups. Her experience as in-house counsel for a large health center provides clients a unique perspective to navigate complex healthcare matters.
Janice provides... strategic and regulatory guidance on the 340B Drug Discount Program, including contract pharmacy arrangements, as well as limited distribution network and other specialty pharmacy models. She has represented specialty pharmacies, health care systems, disproportionate share hospitals, federal grantees, and other 340B-covered entities.
She routinely represents FQHCs on various matters related to the Health Center Program. She advises health centers regarding HRSA Operational Site Visits and other government agency audits, billing and contracting advice, guidance on Federal Tort Claims Act coverage and the 340B Drug Discount Program, as well as other regulatory requirements impacting health center compliance.
Additionally, Janice also advises digital and medical technology companies and providers on privacy and security matters. The increased use of Software as a Medical Device (MaSD) and artificial intelligence in medical technology presents unique cybersecurity issues as the FDA and FTC continue to implement regulatory requirements. She provides strategic advice to her medical technology clients on cybersecurity, privacy, and data protection issues.
Throughout her career, she has represented numerous providers with cybersecurity and cyber-liability issues, telehealth, data strategy, security and privacy, licensure and accreditation of health care facilities, Medicare and Medicaid reimbursement, and billing and coding matters. She has also assisted clients in the development and implementation of collaborative care models, clinically integrated networks, clinical trials contracting and reimbursement, patient safety organizations and employer sponsored on-site health clinics.
Janice routinely represents telehealth providers on licensure, credentialing, privileging, online prescribing and corporate practice of medicine matters. She also drafts and reviews contracts for digital health products and services and assists health care clients with security and risk analysis obligations under federal and state laws.